Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms
The role of Polycomb Repressive Complex 1 (PRC1) is well described in development. Here, the authors investigate canonical PRC1’s regulation of transcriptional programs in breast cancer where, in addition to its repressive function, it is also recruited to oncogenic active enhancers to regulate enha...
Guardado en:
Autores principales: | Ho Lam Chan, Felipe Beckedorff, Yusheng Zhang, Jenaro Garcia-Huidobro, Hua Jiang, Antonio Colaprico, Daniel Bilbao, Maria E. Figueroa, John LaCava, Ramin Shiekhattar, Lluis Morey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc957fd0d811463b9e87699141c6c633 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Polycomb group protein CBX6 is an essential regulator of embryonic stem cell identity
por: Alexandra Santanach, et al.
Publicado: (2017) -
Epigenetic mechanisms in breast cancer therapy and resistance
por: Liliana Garcia-Martinez, et al.
Publicado: (2021) -
Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2
por: Neil Justin, et al.
Publicado: (2016) -
Flipping between Polycomb repressed and active transcriptional states introduces noise in gene expression
por: Gozde Kar, et al.
Publicado: (2017) -
Ash1l methylates Lys36 of histone H3 independently of transcriptional elongation to counteract polycomb silencing.
por: Hitomi Miyazaki, et al.
Publicado: (2013)